RARG and renal carcinoma: MiR-30a expression was widely downregulated in patients’ colorectal, gastric, hepatocellular, lung, oral, pancreatic, prostate, and renal cancer tissues, and accordingly colorectal, hepatocellular, pancreatic, and renal cancer cells are known to overexpress RARγ.